Fund Holdings

Lynx1 Capital Management LP

Filing Period:
Securities
SharesValue ($K)
Q2 2025
Q3 2025
Change
Q2 2025
Q3 2025
Weight (%)
Change
MERUS N V1,568,8411,534,141-34,70082,521,037144,439,37529.40%+61,918,338
STOKE THERAPEUTICS INC(STOK)5,404,6745,404,674061,343,050109,881,25322.37%+48,538,203
GH RESEARCH PLC(GHRS)6,746,9518,601,189+1,854,23882,245,333104,311,67921.23%+22,066,346
PROTAGONIST THERAPEUTICS INC733,014700,014-33,00040,513,68446,501,9309.47%+5,988,246
C4 THERAPEUTICS INC7,098,1337,098,133010,150,33015,757,8553.21%+5,607,525
ADC THERAPEUTICS SA01,325,848+1,325,84805,303,3921.08%+5,303,392
PASSAGE BIO INC0623,704+623,70405,008,3431.02%+5,008,343
DENALI THERAPEUTICS INC(DNLI)0261,687+261,68703,799,6950.77%+3,799,695
TSCAN THERAPEUTICS INC7,857,3477,857,347011,393,15314,300,3722.91%+2,907,219
PRECISION BIOSCIENCES INC1,036,0511,042,596+6,5454,351,4145,755,1301.17%+1,403,716
CULLINAN THERAPEUTICS INC(CGEM)4,400,8425,766,090+1,365,24833,138,34034,192,9146.96%+1,054,574
DESIGN THERAPEUTICS INC65,95465,9540222,265496,6340.10%+274,369
ASSEMBLY BIOSCIENCES INC10,3660-10,366187,8320-187,832
IBIO INC1,538,5731,055,897-482,6761,174,085874,0720.18%-300,013
NEUPHORIA THERAPEUTICS INC45,8060-45,806325,2230-325,223
UPSTREAM BIO INC219,2470-219,2472,407,3320-2,407,332
PASSAGE BIO INC9,256,9530-9,256,9533,705,5580-3,705,558
ALLOGENE THERAPEUTICS INC11,057,009546,119-10,510,89012,494,420677,1880.14%-11,817,232
Page 1 of 1